Rujuk FatwaMalaysian fatwa reference
BM

FatwaSelangorMedicine & Health

Hukum Pengambilan Vaksin Human Papilloma Virus (HPV)

What is the ruling on taking the HPV vaccine to prevent cervical cancer?

Short answer

The Selangor State Fatwa Committee ruled that taking the Human Papilloma Virus (HPV) vaccine is permissible for the purpose of preventing cervical cancer.

SelangorFatwa committee decision

A reference, not a fatwa. First sentence of the summary below — read the original fatwa and consult your state authority before acting.

Authority
Selangor State Mufti Department
Status
Fatwa committee decision
Series
Keputusan Fatwa Tidak Diwartakan
Topic
Medicine & Health

No evidence of gazettement in the source — this is not a gazetted fatwa.

Summary

The Selangor State Fatwa Committee ruled that taking the Human Papilloma Virus (HPV) vaccine is permissible for the purpose of preventing cervical cancer. The ruling relies on expert statements that cervical cancer is often detected late, at the fourth stage, and that its main cause is HPV infection, especially the high-risk types 16 and 18.

Written in our own words from the original fatwa — check the source before acting on it.

Hukum pengambilan Vaksin Human Papilloma Virus (HPV) adalah harus untuk mencegah penyakit kanser pangkal rahim.

Excerpt from the original fatwa · Selangor

Read the full fatwa on the Selangor website (new tab)

How to cite

Cite the original fatwa and its authority. Rujuk Fatwa is only where you found it.

Selangor State Mufti Department. “Hukum Pengambilan Vaksin Human Papilloma Virus (HPV)”, date not stated. https://www.muftiselangor.gov.my/2023/10/26/hukum-pengambilan-vaksin-human-papilloma-virus-hpv/. Found via Rujuk Fatwa: https://rujukfatwa.com/en/fatwa/is-hpv-vaccine-permissible-selangor-2010/

Local graph

This fatwa and its nearest connections. The full lists are below.

See it on the full map

Related fatwas from other authorities

Chosen because the topic is close. Each is a separate fatwa — not necessarily an answer to the same question.